ICL And Lavie Bio Enter Collaboration To Develop Novel Bio-Stimulant Products; ICL To Invest $10M In Lavie Bio
ICL to invest $10 million in Lavie Bio
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company focused